Aspira Pathlab & Diagnostics
ASPIRA · Healthcare > Hospital & Healthcare Services Listing date: Feb. 28, 2018

Stock Price vs Company Growth
1d
0.0%
1w
10.8%
1m
6.9%
3m
109.7%
6m
83.8%
1y
117.4%
5y
28.8%
all
28.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 116 0%
49
136
Company Overview

Sales
22.6 Cr
Growth: 36.5%
Profit after Tax
2.4 Cr
Growth: 18.5%
Micro Cap
120 Cr
P/E: 50.0x
Industry P/E: 50.2x
Fundamentals

Sales (Cr) ₹ 22.6
Growth 36.5%
EBITDA 17.7%
P/S 5.3x
Dividend 0.0%
P/E 50.0x
Book Value ₹ 12.2
PEG Ratio 1.4x
ROE 20.3%
P/B 9.5x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The Company is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations.
Investors (14)